Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)

Ssu Chuan Lai; Yu Ting Su; Ching Chi Chi; Yung Che Kuo; Kam Fai Lee; Yu Chih Wu; Pei Chi Lan; Muh Hwa Yang; Te Sheng Chang; Yen Hua Huang

doi:10.1186/s13046-019-1518-z

Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)

Ssu Chuan Lai
, Yu Ting Su
, Ching Chi Chi
, Yung Che Kuo
, Kam Fai Lee
, Yu Chih Wu
, Pei Chi Lan
, Muh Hwa Yang
, Te Sheng Chang^*
, Yen Hua Huang

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Abstract

In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'(Figure Presented). The authors sincerely apologize for the inconvenience caused to the readers.

Original language	English
Article number	10
Journal	Journal of Experimental and Clinical Cancer Research
Volume	39
Issue number	1
DOIs	https://doi.org/10.1186/s13046-019-1518-z
State	Published - 13 01 2020

Bibliographical note

Publisher Copyright:
© 2020 The Author(s). Reference:.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/s13046-019-1518-z

Fingerprint

Dive into the research topics of 'Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)'. Together they form a unique fingerprint.

Cite this

Lai, S. C., Su, Y. T., Chi, C. C., Kuo, Y. C., Lee, K. F., Wu, Y. C., Lan, P. C., Yang, M. H., Chang, T. S., & Huang, Y. H. (2020). Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2). Journal of Experimental and Clinical Cancer Research, 39(1), Article 10. https://doi.org/10.1186/s13046-019-1518-z

Lai, Ssu Chuan ; Su, Yu Ting ; Chi, Ching Chi et al. / Correction to : DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2). In: Journal of Experimental and Clinical Cancer Research. 2020 ; Vol. 39, No. 1.

@article{411e205c069a4a75a4f3633995ba55ea,

title = "Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)",

abstract = "In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'(Figure Presented). The authors sincerely apologize for the inconvenience caused to the readers.",

author = "Lai, \{Ssu Chuan\} and Su, \{Yu Ting\} and Chi, \{Ching Chi\} and Kuo, \{Yung Che\} and Lee, \{Kam Fai\} and Wu, \{Yu Chih\} and Lan, \{Pei Chi\} and Yang, \{Muh Hwa\} and Chang, \{Te Sheng\} and Huang, \{Yen Hua\}",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s). Reference:.",

year = "2020",

month = jan,

day = "13",

doi = "10.1186/s13046-019-1518-z",

language = "英语",

volume = "39",

journal = "Journal of Experimental and Clinical Cancer Research",

issn = "1756-9966",

publisher = "BioMed Central Ltd",

number = "1",

}

Lai, SC, Su, YT, Chi, CC, Kuo, YC, Lee, KF, Wu, YC, Lan, PC, Yang, MH, Chang, TS & Huang, YH 2020, 'Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)', Journal of Experimental and Clinical Cancer Research, vol. 39, no. 1, 10. https://doi.org/10.1186/s13046-019-1518-z

Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2). / Lai, Ssu Chuan; Su, Yu Ting; Chi, Ching Chi et al.
In: Journal of Experimental and Clinical Cancer Research, Vol. 39, No. 1, 10, 13.01.2020.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)

AU - Lai, Ssu Chuan

AU - Su, Yu Ting

AU - Chi, Ching Chi

AU - Kuo, Yung Che

AU - Lee, Kam Fai

AU - Wu, Yu Chih

AU - Lan, Pei Chi

AU - Yang, Muh Hwa

AU - Chang, Te Sheng

AU - Huang, Yen Hua

PY - 2020/1/13

Y1 - 2020/1/13

N2 - In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'(Figure Presented). The authors sincerely apologize for the inconvenience caused to the readers.

AB - In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'(Figure Presented). The authors sincerely apologize for the inconvenience caused to the readers.

UR - https://www.scopus.com/pages/publications/85077786225

U2 - 10.1186/s13046-019-1518-z

DO - 10.1186/s13046-019-1518-z

M3 - 评论/辩论

C2 - 31931847

AN - SCOPUS:85077786225

SN - 1756-9966

VL - 39

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

IS - 1

M1 - 10

ER -

Lai SC, Su YT, Chi CC, Kuo YC, Lee KF, Wu YC et al. Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2). Journal of Experimental and Clinical Cancer Research. 2020 Jan 13;39(1):10. doi: 10.1186/s13046-019-1518-z

Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this